Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

801.O1.8 Gene Therapy and Transfer

Tuesday, December 9, 2008: 7:00 AM-9:00 AM
304-306-308 - South (Moscone Center)
Moderators:
John Tisdale and Chiara Bonini
7:00 AM
The 3’ End of the Chicken Hypersensitive Site-4 Insulator Has Properties Similar to the 5’ Insulator Core and Is Necessary in Conjunction with the Core for Full Insulator Activity

Paritha Arumugam1*, Fabrizia Urbinati, Phd.2*, Chinavenmeni S. Velu, PhD3, H. Leighton Grimes, PhD4 and Punam Malik, MD5

1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Experimental Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati
3Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Div. of Experimental Hematology and Cancer Biology, Dept of Pediatrics, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

7:15 AM
Evaluation of a γ-Globin Lentiviral Vector in Sickle Cell Mice and Pigtail Macaques

Phillip W Hargrove, M.S.1*, Tamara I Pestina, Ph.D.1*, Yoon Sang Kim, M.D., Ph.D.1*, John Gray, Ph.D.1*, Kelli Boyd, D.V.M., Ph.D.2* and Derek Persons, MD, PhD1

1Hematology, St. Jude Children's Research Hospital, Memphis, TN
2Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN

7:30 AM
Cell-Intrinsic Heterogeneity Plays An Important Role in the Development of Clonal Dominance after Retroviral Gene Transfer into Hematopoietic Stem Cells

Olga S. Kustikova*, Bernhard Schiedlmeier*, Martijn H. Brugman*, Maike Stahlhut*, Zhixiong Li and Christopher Baum

Experimental Hematology, Hannover Medical School, Hannover, Germany

7:45 AM
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome

Claudia Cattoglio1*, Barbara Felice2*, Davide Cittaro2*, Annarita Miccio3*, Giuliana Ferrari1*, Alessandra Recchia4*, Lucilla Luzi2* and Fulvio Mavilio4

1Istituto Scientifico H. San Raffaele, Milan, Italy
2FIRC Institute of Molecular Oncology, Milan, Italy
3Abramson Research Center, Children's Hosp. of Philadelphia, Philadelphia, PA
4Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy

8:00 AM
Hematopoietic Stem Cell Gene Therapy Trial with Lentiviral Vector in X-Linked AdrenoleukodystrophyClinically Relevant Abstract

Marina Cavazzana-Calvo, MD, PhD1, Nathalie Cartier2*, Salima Hacein-Bey Abina1*, Gabor Veres3*, Manfred Schmidt4*, Cynthia Bartholomae4*, Michel Vidaud5*, Liliane Dal-Cortivo1*, Laure Caccavelli1*, Nizar Malhaoui6*, Pierre Frange6*, Véronique Kiermer7*, Denice Mittelstaedt7*, Andrew Simmons7*, Céline Bellesme2*, François Lefrère1*, Chantale Lagresle1*, Stephane Blanche6*, Pierre Charneau8*, Muriel Audit9*, Bruno L'Homme5*, Jing Chao Zhao-Emonet5*, Serge Fichelson10*, Françoise Pflumio10*, Anne Dubart-Kupperschmitt10*, Rachel Salzman11*, Amber Salzman11*, Pierre Bougnères2*, Christof Von Kalle4*, Alain Fischer, MD, PhD12* and Patrick Aubourg2*

1Biothérapie, Hopital Necker - Enfants Malades, Paris, France
2Endocrinologie et Neurologie Pediatrique, AP-HP Hôpital Saint Vincent de Paul, Paris, France
3Applied Genetic Technologies, Corporation, Alachua, FL
4Translational Oncology, National Center for Tumor Diseases (NCT) / German Cancer Research Center (DKFZ), Heidelberg, Germany
5Faculté des Sciences Pharmaceutiques et Biologiques, UMR745 Inserm, Université Paris Descartes,, Paris, France
6Unité d'Immunologie et Hématologie Pédiatrique, AP-HP Hôpital Necker - Enfants Malades, Paris, France
7Cell Genesys, Inc., San Francisco, CA
8CNRS-URA3015, Institut Pasteur, Paris, France
9Généthon, Paris, France
10departement d'Hématologie - INSERM U567, Institut Cochin, Paris, France
11The StopALD Foundation, Houston, TX
12Service d'Immunologie et Hematologie Pediatrique, INSERM, Université Paris Descartes, IFR94, AP-HP Hopital Necker Enfants-Malades, Paris, France

8:15 AM
Immunosuppression Modulates Immune Responses to AAV Capsid in Human Subjects Undergoing Intramuscular Gene Transfer for Lipoprotein Lipase DeficiencyClinically Relevant Abstract

Daniel J Hui, Ph.D.1*, Federico Mingozzi, Ph.D.1*, Annemarie Kleefstra2*, Janneke M Meulenberg, Ph.D.2*, Shyrie Edmonson3*, Denise Morin4*, Daniel Gaudet, M.D., Ph.D.5*, Sander van Deventer, M.D., Ph.D.2* and Katherine A. High, M.D.3

1Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA
2Amsterdam Molecular Therapeutics, Amsterdam, Netherlands
3Howard Hughes Medical Institute, The Children's Hospital of Philadelphia, Philadelphia, PA
4University of Montreal, Montreal, QC, Canada
5Chicoutimi University Hospital, Chicoutimi, QC, Canada

8:30 AM
Recombination of Endogenous TCR Chains with Retrovirally Introduced TCR Chains Can Result in Mixed T Cell Receptor Dimers Harbouring Harmful Alloreactivity

Marleen M van Loenen, MSc*, Renate de Boer, BSc*, Gerdien L Volbeda, BSc*, Avital L Amir, MD*, Renate S. Hagedoorn, MSc*, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD and Mirjam H.M. Heemskerk, PhD

Dept. of Hematology, Leiden University Medical Center, Leiden, Netherlands

8:45 AM
Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy

Valentina Hoyos, MD1*, Barbara Savoldo, MD1*, Juan F Vera, MD1*, Concetta Quintarelli, PhD1*, Cliona M Rooney, PhD2*, Helen E. Heslop, MD3, Malcolm K Brenner, MD, PhD3* and Gianpietro Dotti, MD4*

1Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
2Pediatrics, Molecular Virology and Microbiology, Immunology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
3Pediatrics, Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
4Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

*signifies non-member of ASH